fda compounding semaglutide warning september 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns FDA – Partnership for Safe Medicines

The FDA has warned six online companies for selling compounded retatrutide, an unlicensed weight-loss drug that has gained traction among social media influencers., "All of a sudden, you have

27.05

★★★★☆4.8 (126)

WRTV Investigates has learned the FDA sent 30 warning letters to telehealth companies for illegally marketing compounded GLP-1s. MORE

25.82

★★★★★4.9 (98)

WRTV Investigates has learned the FDA sent 30 warning letters to telehealth companies for illegally marketing compounded GLP-1s. MORE

27.92

★★★★★5.0 (157)

FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products

24.34

★★★★★4.7 (84)

🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these

25.99

★★★★★4.9 (203)

FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in the U.S. drug supply chain. The agency recently seized dozens of units of counterfeit Ozempic (semaglutide) injection 1 mg that were

27.06

★★★★★5.0 (176)

FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

21.07

★★★★★4.8 (132)